Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Human Coagulation Factor VIIa for Hemophilia With Inhibitors
CTR20231915Phase 3Completed
- Sponsor
- Chengdu Rongsheng Pharmaceutical
- Start
- Jun 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of coagulation factor VIIa in hemophilia A, hemophilia B (HB), sponsored by Chengdu Rongsheng Pharmaceutical. Started Jun 2023; status: completed.
02
Drugs
coagulation factor VIIa
03
Conditions
hemophilia Ahemophilia B (HB)
Beyond the preview
Go deeper on CTR20231915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231915.